PCS6422

About Processa Pharmaceuticals

Processa Pharmaceuticals is a publicly traded, development-stage company leveraging deep regulatory expertise to efficiently advance de-risked drug candidates toward FDA approval. The company's strategy centers on identifying assets with prior human proof-of-concept, designing optimized clinical trials, and aiming to out-license programs before or after pivotal studies. With a patient-centric focus and a leadership team boasting over 30 FDA drug approvals, Processa targets capital-efficient development in areas like oncology and gastrointestinal motility disorders.

Therapeutic Areas